当前位置: 首页 > 期刊 > 《医学信息》 > 20143
编号:13703883
DC—CIK细胞治疗恶性肿瘤对患者肝肾功的影响(2)
http://www.100md.com 2014年1月22日 耿奇 李秀萍
第1页

    参见附件。

     [3]Lee DH, Ha MH, Chrisianl DC. Body weight,alcohol consumption and liver enzyme activity :a 42 year follow study [J].Int J Epidemiol, 2001,30(4):766-770

    [4]Hongeng S. Petvises S. Worapong pailboom S. et al. Generation of CD3+CD56+ cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer cells[J],Int J Hematol.2003.77(2):175-179

    [5] Olioso P, GiancolA R, Di Riti M, et al. Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial. Hematol Oncol, 2009, 27: 130-139.

    [6]Marten A, Ziske C, Schottker B, et al. Interaction between dendritic cells and cytokine induced killer cells lead to an activation of both populations. Immunother, 2001, 24: 502-510.

    [7]Sabado RL, Bhardwai N. Directing dendritic cell immunotherapy to- wards successful cancer treatment. Immunotherapy. 2010, 2: 37-56.

    [8]Young JW, Merad M, Hart DN. Dendritic cells in transplantation and immune-based therapies. Biol Blood Marrow Transplant, 2007, 13: 23-32.编辑/申磊

    

您现在查看是摘要介绍页,详见PDF附件